FINDEX Résultats passés
Passé contrôle des critères 6/6
FINDEX has been growing earnings at an average annual rate of 17.3%, while the Healthcare Services industry saw earnings growing at 17.3% annually. Revenues have been growing at an average rate of 5.3% per year. FINDEX's return on equity is 27.6%, and it has net margins of 24%.
Informations clés
17.3%
Taux de croissance des bénéfices
17.3%
Taux de croissance du BPA
| Healthcare Services Croissance de l'industrie | 19.2% |
| Taux de croissance des recettes | 5.3% |
| Rendement des fonds propres | 27.6% |
| Marge nette | 24.0% |
| Prochaine mise à jour des résultats | 13 Nov 2024 |
Mises à jour récentes des performances passées
Recent updates
FINDEX Inc.'s (TSE:3649) Popularity With Investors Is Under Threat From Overpricing
Sep 05
FINDEX (TSE:3649) Will Pay A Dividend Of ¥7.00
Jun 07FINDEX (TSE:3649) Is Due To Pay A Dividend Of ¥7.00
Apr 25FINDEX (TSE:3649) Is Due To Pay A Dividend Of ¥7.00
Apr 11After Leaping 29% FINDEX Inc. (TSE:3649) Shares Are Not Flying Under The Radar
Mar 10Ventilation des recettes et des dépenses
Comment FINDEX gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 30 Jun 24 | 6,147 | 1,477 | 1,931 | 0 |
| 31 Mar 24 | 6,064 | 1,502 | 1,885 | 0 |
| 31 Dec 23 | 5,191 | 1,059 | 1,832 | 0 |
| 30 Sep 23 | 5,016 | 940 | 1,766 | 0 |
| 30 Jun 23 | 4,557 | 686 | 1,706 | 0 |
| 31 Mar 23 | 4,528 | 663 | 1,700 | 0 |
| 31 Dec 22 | 4,541 | 722 | 1,694 | 0 |
| 30 Sep 22 | 4,454 | 500 | 1,681 | 0 |
| 30 Jun 22 | 4,796 | 615 | 1,685 | 0 |
| 31 Mar 22 | 4,770 | 580 | 1,656 | 0 |
| 31 Dec 21 | 4,968 | 636 | 1,635 | 0 |
| 30 Sep 21 | 4,550 | 573 | 1,593 | 0 |
| 30 Jun 21 | 4,149 | 395 | 1,554 | 0 |
| 31 Mar 21 | 3,836 | 297 | 1,483 | 0 |
| 31 Dec 20 | 4,004 | 430 | 1,483 | 0 |
| 30 Sep 20 | 3,697 | 246 | 1,532 | 0 |
| 30 Jun 20 | 4,620 | 689 | 1,559 | 0 |
| 31 Mar 20 | 4,741 | 751 | 1,621 | 0 |
| 31 Dec 19 | 4,281 | 499 | 1,587 | 0 |
| 30 Sep 19 | 5,129 | 1,035 | 1,560 | 0 |
| 30 Jun 19 | 4,072 | 548 | 1,510 | 0 |
| 31 Mar 19 | 3,839 | 467 | 1,429 | 0 |
| 31 Dec 18 | 3,603 | 398 | 1,400 | 0 |
| 30 Sep 18 | 3,166 | 174 | 1,336 | 0 |
| 30 Jun 18 | 3,255 | 255 | 1,356 | 0 |
| 31 Mar 18 | 3,519 | 422 | 1,376 | 0 |
| 31 Dec 17 | 3,311 | 366 | 1,347 | 0 |
Des revenus de qualité: 3649 has high quality earnings.
Augmentation de la marge bénéficiaire: 3649's current net profit margins (24%) are higher than last year (15.1%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: 3649's earnings have grown by 17.3% per year over the past 5 years.
Accélération de la croissance: 3649's earnings growth over the past year (115.3%) exceeds its 5-year average (17.3% per year).
Bénéfices par rapport au secteur d'activité: 3649 earnings growth over the past year (115.3%) exceeded the Healthcare Services industry 11.9%.
Rendement des fonds propres
ROE élevé: 3649's Return on Equity (27.6%) is considered high.